IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant
... mortality during the first six months following
transplantation and is a key concern for transplant recipients ... system is compromised -- as after solid organ
transplantation -- CMV can cause serious illness with long-term ... Gaston, Medical Director for Kidney and Pancreas
transplantation and Professor of Medicine, University of Alabama ...
Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
... following allogeneic and autologous bone marrow
transplantation (BMT), peripheral blood stem cell (PBSC) ... reconstitution in patients undergoing PBSC
transplantation and bone marrow
transplantation failure or engraftment delay. Leukine is ...
David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
... , and Dr. Yoshifumi Naka, Director of cardiac
transplantation at NewYork-Presbyterian Hospital/ Columbia ... Feldman is Director of Heart Failure and Cardiac
transplantation and Director of Heart Failure and Transplant ... from severe heart failure do not qualify for
transplantation due to other health issues. An alternative for ...
Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
... Kidney
transplantation to be Quark's second indication with ... Patients that develop DGF following renal
transplantation have inferior kidney graft survival compared to ... the immediate postoperative period in renal
transplantation and affects 25-40% of the deceased donor renal ...
Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes
... of stem cell source and patient age on stem cell
transplantation outcomes will be explored at a press conference ... the presence of stem cells in cord blood for
transplantation will also be shared during the press conference. ... therapy, and stem cell transplantation. Stem cell
transplantation is the process by which blood stem cells are ...
Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit
... this area, having
already completed two myoblast
transplantation research studies in patients
suffering from ... that Myoblast Therapy may someday replace
heart
transplantation as the primary option for patients with severe ... been treated worldwide using
myoblasts. Myoblast
transplantation for congestive heart failure is
investigational ...
Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
... three weeks
post-MI and eight weeks post-cell
transplantation in the SDF-MB treated
animals. By comparison, and ... to
greater improvement in cardiac function after
transplantation compared to
non-modified myoblasts," said Dr. ... cell homing (attraction of other stem cells
to
transplantation site for the purpose of helping with the ...
ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
... versus
host disease (GvHD) after bone marrow
transplantation and graft rejection
after solid organ ... stem cell transplantation. Following
transplantation and
transplant engraftment, eligible patients ... stem cell (bone marrow) or
solid organ
transplantation are at high risk of CMV infection. In ...
Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting
... Satellite Symposium
3: The Challenges of Lung
transplantation in Cystic Fibrosis (CF) at the
International Society of Heart and Lung
transplantation (ISHLT) Annual
Meeting & Scientific Sessions, ... is an Absolute Contradiction to
transplantation between Duane
Davis, MD, Duke University Medical ...
Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
... said Steven Tsui,
M.D., F.R.C.S., Director of
transplantation and Surgeon, Papworth Hospital,
U.K. "In ... the donor."
NON-HEART-BEATING DONORS
Organ
transplantation is currently limited by a shortage of ... The International Society for Heart and Lung
transplantation (ISHLT) is
a not-for-profit organization ...
Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
... -- Commenting on a study
of lung
transplantation for children with cystic fibrosis, a ... the new study found no lower
threshold at which
transplantation provided better survival in children --
a finding ... cystic fibrosis in the U.S., it also offers
lung
transplantation among its treatments. The Center staff works ...
Allegheny General Hospital Performs First Liver Transplant
... as a status 1A candidate and underwent liver
transplantation surgery
three days later. The surgery was ... by Thomas V. Cacciarelli, M.D., director of
Liver
transplantation at AGH, and Dr. Roh. After the six-hour ... UNOS data also shows that the demand for liver
transplantation has been
steadily increasing over the past five ...
UCLA Program Aims to Revolutionize Kidney Transplants
... be as long as five years, making
living-donor
transplantation an attractive alternative. Living donors,
often ... of cases. The door to increasing living-donor
transplantation also has been
opened wider with pioneering ... M.D., director of Kidney and
Kidney/Pancreas
transplantation at UCLA. To view a video about an actual living ...
UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
... for patients with diseases like leukemia and lymphoma."
Bone marrow
transplantation is a life-saving treatment for many types of
leukemia and lymphoma. ... products. The company is developing a pipeline of products in
stem cell
transplantation and in tissue regeneration to effectively treat
debilitating and often ...
WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
... Liberty Science Center. He is the Region 2 Representative on the Pancreas
transplantation Committee for the United Network for Organ Sharing.
He was also the ... In 2005, he received the National Medical Award for Excellence in
transplantation by the Kidney and Urology Foundation of America, Inc.
Saint ...
Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
... Chief of the Multiple Myeloma Program, Bone Marrow and Blood Stem Cell
transplantation at St. Vincent's Comprehensive Cancer Center in New York, at the 2009 ... Professor of Medicine, Division of Oncology, Section of Bone Marrow
transplantation at Washington University School of Medicine in a poster titled ...
Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
... In less than 20 hours, Yoshifumi Naka, MD, PhD, director of cardiac
transplantation at NewYork-Presbyterian Hospital/ Columbia University Medical Center and ... number of people who suffer from severe heart failure do not qualify for
transplantation due to other health issues. An alternative for these patients is access to ...
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
... additional therapy), development of hepatocellular carcinoma (HCC), liver
transplantation or death. All events other than
transplantation and death were adjudicated by an independent committee of experts blinded ...
An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
... date will be presented during the International Society for Heart and Lung
transplantation Annual Meeting in Paris, France on April 24, 2009
COLUMBIA, Md., ... identifying patients at risk for infection or rejection following heart
transplantation has not been cleared by the U.S. Food & Drug Administration. The ...
Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients
... Sustained Benefits for Patients Awaiting
transplantation
ANN ARBOR, Mich., April 7 /PRNewswire/ -- The DuraHeart(TM) Left ... number of people who suffer from severe heart failure do not qualify for
transplantation due to other health issues. An alternative for these patients is access to ...
Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
...
The medical team led by Yoshifumi Naka, M.D., Ph.D., director of cardiac
transplantation at NewYork-Presbyterian Hospital/ Columbia University Medical Center and ... number of people who suffer from severe heart failure do not qualify for
transplantation due to other health issues. An alternative for these patients is access to ...
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
... multicenter study intended to enroll 348 subjects who have undergone liver
transplantation and are at high-risk of developing CMV disease (i.e., donor CMV ... following hematopoietic stem cell (bone marrow) or solid organ
transplantation are at high risk of CMV infection. In these patients, CMV disease can ...
ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers
... taking too much acetaminophen pain medicine.
For ALF patients, liver
transplantation is the only therapy proven to impact survival. However, it has a cost ... Winters, Ph.D., said, "With the continuing shortage of donor livers for
transplantation and the large number of patients unlisted for transplant, patients are ...
Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant
... when the Clinic's Institutional Review Board (IRB) announced that face
transplantation is both ethical and possible by approving the first protocol for the ... Eghtesad, M.D., Staff Surgeon in the Departments of General Surgery and
transplantation
Chad Gordon, D.O., Fellow in the Department of Plastic Surgery
...
Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
... myeloid reconstitution following allogeneic and autologous bone marrow
transplantation (BMT), peripheral blood stem cell (PBSC) mobilization and subsequent ... in patients undergoing PBSC transplantation, and bone marrow
transplantation failure or engraftment delay. Leukine is available in two formulations, ...
Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
... diagnosed with AML, ALL or MDS eligible for an allogeneic bone
marrow
transplantation but for whom no matching donor is available.
"Bone marrow ... which may enable a safe and
potentially life-saving mismatched bone marrow
transplantation as a treatment
option for end-stage blood cancer patients."
For ...
New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation
... -- A recently published article by
Sanchez-Velasco et al.* in Clinical
transplantation has expanded our
understanding of the clinical potential of monitoring ... adult patient populations undergoing
immunosuppressive therapy for organ
transplantation by measuring the
concentration of adenosine triphosphate (ATP) released ...
New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients
... et al. ImmuKnow: a new parameter in
immune monitoring of pediatric liver
transplantation recipients. Liver
Transplant. 2008;14:893-898.
About ImmuKnow(R)
... adult patient populations undergoing
immunosuppressive therapy for organ
transplantation by measuring the
concentration of adenosine triphosphate (ATP) released ...
University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
... University of Miami Transplant Laboratories.
Patients undergoing kidney
transplantation were immunosuppressed
post-transplant and their immunosuppressed state was ... adult patient populations undergoing immunosuppressive
therapy for organ
transplantation by measuring the concentration of
adenosine triphosphate (ATP) released ...
Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
... with autologous stem cell
transplantation (ASCT) in patients with relapsed or ... autologous stem cell
transplantation for relapsed/refractory B-cell ...
Biomarkers May Reduce the Need for Biopsies and Offer Personalized Care for Heart and Lung Transplant Patients
... and Scientific Sessions of the International Society for
Heart and Lung
transplantation (ISHLT) suggest the potential of a
significant impact of using biomarkers ... the horizon.
About ISHLT
The International Society for Heart and Lung
transplantation (ISHLT) is
a not-for-profit organization dedicated to the advancement of ...
New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
... Program will be discussed at the International Society
for Heart and Lung
transplantation (ISHLT) 28th Annual Meeting and
Scientific Sessions. The meeting is ... as well.
About ISHLT
The International Society for Heart and Lung
transplantation (ISHLT) is
a not-for-profit organization dedicated to the advancement of ...
Northwestern Memorial Transplant Program Initiates New Study
... is working with Northwestern
Memorial Hospital's department of organ
transplantation to enroll
qualifying subjects in a new research study that seeks to ... person to person, and an HLA compatibility test is performed
before organ
transplantation to find out if tissues match between a donor
and a recipient.
The ...
Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkin's Lymphoma
... (RIT) to high-dose chemotherapy
(HDC) followed by autologous stem-cell
transplantation (ASCT) produced a
high rate (70 percent) of progression-free survival at ... in combination with high-dose chemotherapy (BEAM) and
autologous stem-cell
transplantation for treatment of non-Hodgkin's
lymphoma, determinations by regulatory, ...
New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
... versus VAD as Induction Treatment Prior to Autologous Stem Cell
transplantation (ASCT) in Newly Diagnosed Multiple Myeloma - Lead investigator: ... Dexamethasone (TD) in Preparation for Autologous Stem-Cell (SC)
transplantation (ASCT) in Newly Diagnosed Multiple Myeloma - Lead investigator: ...
Vital Therapies Announces Presentation of ELAD(R) 'Artificial Liver' Data at American Association for the Study of Liver Diseases 2007 Annual Meeting
... in China and advance our
U.S. clinical program." To date, only liver
transplantation has been shown to increase
survival. However, demand for liver
transplantation far exceeds the supply
of donor livers, creating a need for an ...
CuraGen Announces Top-Line Phase II Results on Velafermin
... receiving high-dose chemotherapy followed by
autologous bone marrow
transplantation (BMT). The trial enrolled 390
patients at 33 centers in the United States. ... Time: 4:00 p.m. Eastern Time Session: Clinical Care:
transplantation Regimen Toxicities and Engraftment-Regimen-Related ...
Benitec MOU With CalbaTech, Inc.
... stem cells from HIV infected
individuals to be cryopreserved for future
transplantation into a client
for medical purposes. All other stem cell collection ... to harvest stem cells in micro quantities to
be cryopreserved for future
transplantation into a client for medical
purposes. The collection of stem cells from two ...
Is Your Hair Taking a Break?
... oral medications also may be an option for women who may not want to spend time applying minoxidil every day. Dr. McMichael also noted that hair
transplantation is an extremely effective procedure for women who want to fully restore their lost hair and works best in conjunction with topical or oral ...
USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic
... schools in federally sponsored research (Association of American Medical Colleges, 2003). Research programs in genetics, cancer, neurogenetics,
transplantation medicine, and other key areas have attracted national recognition. The School's dual commitments to collaborative interdisciplinary research and ...